Is TMS Therapy Safe? What Patients Need to Know

Is TMS Therapy Safe for Most Patients?

Is TMS therapy safe? For appropriately screened patients receiving treatment from a trained clinical team, Transcranial Magnetic Stimulation has a well-established safety record and is generally well tolerated. TMS is noninvasive, does not require surgery, and ordinarily does not require anesthesia or sedation. Patients remain awake during treatment and can generally return to their usual activities after the session.

That does not mean TMS is completely without risks or side effects. It is a medical treatment that directly influences brain activity, so appropriate screening, accurate treatment settings, trained technicians, medical oversight, and ongoing monitoring all matter. The right question is therefore not simply whether TMS is safe in the abstract. The better question is whether TMS is safe and appropriate for a particular patient, using a particular protocol, after that person’s medical history, medications, neurological history, implanted devices, and treatment goals have been reviewed.

Why TMS Has a Different Side-Effect Profile From Medication

One reason patients are interested in TMS is that the treatment does not require a medication to circulate throughout the body. Antidepressants can be extremely valuable, but because medications are systemic, some patients experience effects involving appetite, weight, gastrointestinal function, sexual function, sleep, sedation, or other parts of the body.

TMS works differently. A treatment coil positioned against the scalp produces magnetic pulses that induce small electrical currents in a targeted area of the brain. Because the treatment is localized rather than delivered systemically through the bloodstream, it generally does not produce the same pattern of whole-body side effects associated with antidepressant medications.

That does not make TMS universally better than medication. They are different treatment tools with different benefits, limitations, and risks. For patients who have struggled with medication side effects or who want to explore a non-medication approach, however, the safety and side-effect profile of TMS can be particularly appealing.

Common TMS Side Effects

The most common TMS side effects occur around the treatment itself and are usually temporary. Patients may experience scalp discomfort or tenderness where the coil is positioned, headache, facial or scalp muscle contractions during stimulation, dizziness, or lightheadedness. Some patients notice that the tapping sensation feels fairly strong during their first treatments but becomes easier to tolerate as they become accustomed to it.

These effects can often be addressed by the technician helping to adjust positioning, gradually increasing stimulation when clinically appropriate, or making other comfort adjustments while preserving the treatment plan. Patients should tell the technician when something feels unusually painful or significantly different from prior sessions rather than assuming they simply have to tolerate it.

TMS equipment also produces repeated clicking sounds during treatment, which is why offering appropriate hearing protection is an important part of safe treatment delivery. Safety includes many small details like this that patients may never think about when treatment is being performed correctly.

The Rare but Important Risk of Seizure

The most serious well-recognized acute risk of TMS is seizure, but this risk is extremely low when patients are appropriately screened and treatment is delivered within established safety parameters. This is particularly reassuring with modern TMS technology and carefully controlled treatment protocols.

Dynamic Psychiatry & Wellness uses an advanced Magstim TMS system, and Magstim technology has demonstrated an excellent safety record in clinical research. In one published accelerated theta-burst study involving patients with treatment-resistant depression, participants received 50 TMS sessions each using Magstim technology, with no seizures or other severe adverse events reported. Other randomized clinical research using Magstim stimulators has likewise reported treatment without seizures.

That does not mean the risk is zero. Rare seizure events have been reported with TMS, including isolated reports involving Magstim systems after they entered broader clinical use. This is why the quality of the clinical program matters just as much as the quality of the equipment. Patient selection, medication review, sleep, neurological history, substance use or withdrawal, accurate motor-threshold determination, stimulation parameters, and technician training all contribute to keeping the risk as low as possible.

Screening therefore includes more than asking whether someone currently has epilepsy. Providers need to understand any personal history of seizures, neurological disease, significant head injury, medication use or recent medication changes, sleep deprivation, alcohol or sedative withdrawal, and other factors that could lower seizure threshold. A prior seizure does not automatically answer the question by itself; the complete risk profile needs to be evaluated.

The combination of an advanced Magstim TMS system with careful screening, accurate treatment delivery, trained technicians, and medical oversight allows us to offer TMS with a very low seizure risk while still recognizing and preparing for this rare potential complication.

TMS, Metal Implants, and Electronic Devices

Metal and implanted devices are another important part of TMS safety screening. Because TMS generates a rapidly changing magnetic field, certain conductive, ferromagnetic, magnetic-sensitive, or electronically controlled implants near the treatment coil can create safety concerns. Examples may include some cranial implants, cochlear implants, implanted neurostimulators, deep brain stimulation systems, medication pumps, or other electronic medical devices.

This does not mean that every piece of metal in or around the body automatically prevents someone from receiving TMS. Dental work, for example, is not generally treated the same way as an electronic or magnetic-sensitive implant near the treatment site. The exact device, material, location, manufacturer guidance, and TMS system all matter.

Patients should therefore tell the treatment team about every implanted medical device, metal fragment, prior cranial surgery, or other potentially relevant material before beginning treatment. When there is uncertainty, the correct approach is to verify the specific implant rather than guess.

Pregnancy and TMS Therapy

Pregnancy deserves individualized consideration, but current research on TMS during pregnancy is reassuring. Unlike a medication taken systemically, TMS does not require an antidepressant to circulate through the mother’s bloodstream and reach the fetus. This makes TMS an important treatment option to consider when significant depression develops during pregnancy and a patient or treatment team wants to minimize fetal medication exposure.

A [2021 systematic review and meta-analysis of TMS for peripartum depression](the 2021 systematic review and meta-analysis) evaluated 11 studies and found meaningful improvement in depressive symptoms, with no severe adverse effects reported in mothers or fetuses. A later [2023 systematic review specifically examining fetal and newborn safety](the 2023 fetal and newborn safety review) evaluated 23 studies and found that although some mothers experienced mild side effects, none of the included studies reported major adverse effects in newborns.

Another review examining reported TMS exposure during pregnancy found 67 births across 20 years of published reports, including treatment during all three trimesters, and reported no serious events involving either mothers or babies. The authors appropriately cautioned that larger standardized studies are still needed before absolute conclusions can be made. Review of fetal risk with TMS during pregnancy

These findings are encouraging, but they should not be interpreted to mean that TMS during pregnancy has been studied as extensively as TMS in the general adult population. Pregnancy research remains comparatively limited, and the absence of a demonstrated fetal safety signal is not the same as proving that risk is zero. More recent reviews continue to describe the short-term safety findings as reassuring while emphasizing the need for larger and better-controlled studies.

For that reason, pregnancy should not automatically exclude someone from TMS, nor should TMS be described as completely risk-free during pregnancy. The decision should be individualized by considering the severity of the mother’s depression, the risks of leaving that depression untreated, previous treatment response, medication options, gestational stage, obstetric care, and the specific TMS protocol being considered.

For some pregnant patients—particularly those with significant depression who have not responded adequately to psychotherapy or who want to limit medication exposure—TMS may offer a valuable non-medication treatment option. The decision should be made collaboratively with appropriate psychiatric and obstetric oversight so that both maternal mental health and fetal well-being remain part of the treatment plan.

What Happens During a TMS Session

TMS treatment is performed while the patient is awake and seated comfortably. The treatment coil is positioned against the scalp at the prescribed location, and magnetic pulses are delivered according to the selected protocol. Patients commonly feel a tapping sensation against the scalp and hear clicking from the coil. There is no routine anesthesia, and there is generally no post-sedation recovery period.

Unlike ketamine therapy, TMS ordinarily does not produce an altered state of consciousness, dissociation, or an acute psychedelic-like psychological experience. Patients remain themselves throughout the session and can communicate normally with the technician. This makes the treatment experience relatively straightforward for many patients.

Session duration varies considerably depending on the protocol. Some protocols take only a few minutes, while others are longer. The safety principles remain the same: accurate positioning, appropriate treatment settings, patient observation, and communication throughout the session.

Why Trained TMS Technicians Matter for Safety

The technician plays an important role in maintaining safe and consistent treatment delivery. Technicians repeatedly perform measurements, position the patient and treatment coil, verify the prescribed setup, monitor comfort, observe how the patient is tolerating treatment, and communicate concerns or changes to the clinical team.

Technicians do not replace the medical provider responsible for clinical decisions, but they are often the team members who see the patient most frequently. That repeated contact makes them important observers. A patient may mention a medication change, new neurological symptom, worsening mood, unusual discomfort, missed sleep, or another change that deserves clinical attention.

At Dynamic Psychiatry & Wellness, technicians complete our TMS Certification Program so that they understand not only how to operate the equipment, but why measurement, positioning, consistency, observation, safety procedures, and communication matter throughout treatment.

Why Medical Oversight Matters

TMS should not become a mechanical process where a patient completes sessions without anyone considering how the patient is actually doing. Clinical oversight includes reviewing response, tolerability, medication changes, emerging symptoms, side effects, safety concerns, and whether the treatment plan remains appropriate.

This becomes especially important when something changes. A new medication may affect seizure threshold. A patient may develop new neurological symptoms. Someone with depression may become more severely depressed or develop suicidal thinking because the underlying illness is progressing despite treatment. A person with bipolar disorder may develop symptoms concerning for hypomania or mania. These situations require clinical judgment rather than simply continuing the same protocol automatically.

Medical supervision does not mean a physician has to sit beside the patient during every pulse. It means the treatment operates within a clinical system where trained technicians observe the patient, clinicians remain involved, relevant changes are communicated, and treatment decisions are made by appropriate medical professionals.

Psychological Safety During TMS

TMS usually does not create the same acute emotional vulnerability that can occur with ketamine-assisted therapy, but psychological monitoring still matters. Patients receiving TMS are often being treated for significant depression or another mental health condition. Their symptoms can change during the course of treatment, whether because the TMS is helping, the illness is worsening, outside circumstances are changing, or another part of the treatment plan needs attention.

Improvement can sometimes produce changes patients did not immediately anticipate. A person who has been severely depressed may begin feeling more energy before every depressive thought has resolved. Another may become increasingly aware of relationship problems or life circumstances that were previously obscured by profound depression. This does not make TMS psychologically dangerous, but it reinforces the value of treating the whole person rather than watching only a depression score.

Not Every TMS Protocol Has the Same FDA Status

Patients may hear that TMS is “FDA-cleared,” but that phrase requires some precision. FDA clearance applies to particular devices, protocols, and indications. TMS has received FDA authorization for several clinical uses, but that does not mean every possible TMS protocol or every symptom treated with TMS has independently received FDA clearance.

Dynamic Psychiatry & Wellness offers a broad range of TMS programs because different neural circuits can be targeted for different clinical goals. Some applications may use FDA-cleared indications and protocols, while others may involve off-label clinical use based on study results, patient’s symptoms, available research, the capabilities of the TMS system, and physician judgment.

Off-label use does not automatically mean inappropriate care; off-label treatment is common throughout medicine. It does mean patients deserve accurate information about what is established, what is emerging, what is FDA-cleared for a particular device and indication, and what remains an individualized clinical application.

How Our TMS Technology Supports Safe Treatment

Dynamic Psychiatry & Wellness uses one of the most advanced TMS systems available, allowing our clinical team to deliver a broad range of treatment protocols and address different brain targets. Advanced technology gives clinicians more flexibility, but technology by itself does not create safety.

The system still has to be used correctly. Safe treatment depends on appropriate patient selection, accurate measurements, individualized treatment settings, trained technicians, careful positioning, monitoring, and clinical oversight. An advanced TMS system is valuable because it gives a trained team more treatment capabilities; it does not replace the trained team.

Who Needs Additional Evaluation Before TMS?

Every patient needs screening, but certain histories deserve particular attention. These include prior seizures or epilepsy, significant neurological conditions, traumatic brain injury, implanted electronic or magnetic-sensitive devices, metal near the treatment area, medications or medication changes that may alter seizure threshold, substance withdrawal, bipolar disorder or prior mania, pregnancy, and other medical or psychiatric concerns that may affect risk.

The purpose of screening is not simply to create a long list of people who are automatically excluded. It is to understand risk. Some findings may represent a contraindication to a particular TMS system or protocol. Others may require additional review, modification, consultation, or monitoring. Good patient selection is one of the most important parts of TMS safety.

What Makes TMS Therapy Safe at Dynamic Psychiatry & Wellness

At Dynamic Psychiatry & Wellness, safety is built into the treatment process rather than added afterward. Patients undergo clinical evaluation before beginning treatment. Treatment location and stimulation settings are determined carefully. Individual head size and anatomy are accounted for during setup. Trained technicians reproduce the prescribed positioning, monitor the patient during sessions, and communicate concerns to the clinical team. Providers remain involved in evaluating symptoms, response, medications, and the larger treatment plan.

Our advanced TMS technology expands what we are able to offer, but we believe the quality of the clinical system surrounding that technology matters just as much. Equipment, technician training, medical judgment, precision, and ongoing observation work together.

The Bottom Line: Is TMS Therapy Safe?

For appropriately selected patients, TMS is generally considered a safe and well-tolerated brain stimulation treatment. Its most common side effects are usually localized and temporary, while serious complications such as seizure are rare. TMS does not require routine anesthesia or sedation, does not involve medication circulating throughout the body, and generally allows patients to resume normal activities after treatment.

Safety, however, should never be assumed simply because TMS is noninvasive. Proper screening, accurate treatment delivery, hearing protection, awareness of implants and seizure risk, trained technicians, clinical oversight, and ongoing communication all matter.

At Dynamic Psychiatry & Wellness, our goal is not simply to offer TMS. It is to provide TMS within a careful clinical system that combines advanced technology with trained technicians, precision treatment delivery, and medical oversight so each patient receives brain-based treatment that is appropriate for their individual situation.